Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C.

Takagi, H; Nagamine, T; Abe, T; Takayama, H; Sato, K; Otsuka, T; Kakizaki, S; Hashimoto, Y; Matsumoto, T; Kojima, A; Takezawa, J; Suzuki, K; Sato, S; Mori, M

Takagi, H; Nagamine, T; Abe, T; Takayama, H; Sato, K; Otsuka, T; Kakizaki, S; Hashimoto, Y; Matsumoto, T; Kojima, A; Takezawa, J; Suzuki, K; Sato, S; Mori, M.

Affiliation

Takagi H; The First Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Gunma, Japan. htakagi@med.gunma-u.ac.jp

J Viral Hepat ; 8(5): 367-71, 2001 Sep.

Article in En | MEDLINE | ID: mdl-11555194

Subject(s)

Carnosine/analogs & derivatives; Carnosine/therapeutic use; Hepatitis C, Chronic/drug therapy; Interferons/therapeutic use; Organometallic Compounds/therapeutic use; Zinc/therapeutic use; Adult; Carnosine/administration & dosage; Carnosine/adverse effects; Carnosine/pharmacology; DNA, Viral/blood; Drug Synergism; Drug Therapy, Combination; Female; Genotype; Hepacivirus/drug effects; Hepacivirus/genetics; Hepatitis C, Chronic/virology; Humans; Interferons/administration & dosage; Interferons/pharmacology; Logistic Models; Male; Middle Aged; Organometallic Compounds/administration & dosage; Organometallic Compounds/adverse effects; Organometallic Compounds/pharmacology; Treatment Outcome; Viral Load; Zinc/administration & dosage; Zinc/adverse effects; Zinc/pharmacology; Zinc Compounds

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Organometallic Compounds / Zinc / Carnosine / Interferons / Hepatitis C, Chronic Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: J Viral Hepat Year: 2001 Type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links